28 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Transgene Biotek Ltd.

BSE

  • 1.80 -0.02 (-1.1%)
  • Vol: 7855
  • BSE Code: 526139
  • PREV. CLOSE
    1.82
  • OPEN PRICE
    1.91
  • BID PRICE (QTY.)
    1.80(13476)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Transgene Biotek Ltd. Cash Flow

Select year
(Rs.in Million)
Particulars
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Profit Before Tax
-191.35
-1334.04
-20.34
172.52
1.68
Adjustment
220.94
157.61
142.94
9.22
10.21
Changes In working Capital
5.66
1155.37
7.35
70.75
-21.26
Cash Flow after changes in Working Capital
35.25
-21.05
129.95
252.48
-9.37
Cash Flow from Operating Activities
35.25
-21.05
129.95
253.42
-10.57
Cash Flow from Investing Activities
-45.73
14.55
-153.54
-1441.47
-667.26
Cash Flow from Financing Activities
10.27
5.97
24.16
827.16
1038.33
Net Cash Inflow / Outflow
-0.22
-0.54
0.57
-360.89
360.49
Opening Cash & Cash Equivalents
0.52
1.05
0.48
361.38
0.89
Cash & Cash Equivalent on Amalgamation / Take over / Merger
NA
NA
NA
NA
NA
Cash & Cash Equivalent of Subsidiaries under liquidations
NA
NA
NA
NA
NA
Translation adjustment on reserves / op cash balalces frgn subsidiaries
NA
NA
NA
NA
NA
Effect of Foreign Exchange Fluctuations
NA
NA
NA
NA
NA
Closing Cash & Cash Equivalent
0.30
0.52
1.05
0.48
361.38